BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16362409)

  • 1. Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion.
    Toh U; Fujii T; Seki N; Niiya F; Shirouzu K; Yamana H
    Cancer Immunol Immunother; 2006 Oct; 55(10):1219-27. PubMed ID: 16362409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade.
    Oida T; Mimatsu K; Kano H; Kawasaki A; Kuboi Y; Fukino N; Amano S
    World J Gastroenterol; 2010 Feb; 16(6):740-4. PubMed ID: 20135723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
    Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer.
    Tomkowski WZ; Filipecki S
    Lung Cancer; 1997 Mar; 16(2-3):215-22. PubMed ID: 9152952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy of cancer using activated autologous lymphocytes--current status and new strategies.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Shimizu K; Minami K; Hihara J; Miyahara E; Toge T
    Hum Cell; 2003 Dec; 16(4):183-9. PubMed ID: 15147038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.
    Mulders P; Tso CL; Pang S; Kaboo R; McBride WH; Hinkel A; Gitlitz B; Dannull J; Figlin R; Belldegrun A
    J Immunother; 1998 May; 21(3):170-80. PubMed ID: 9610908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade.
    Tomkowski WZ; Wiśniewska J; Szturmowicz M; Kuca P; Burakowski J; Kober J; Fijałkowska A
    Support Care Cancer; 2004 Jan; 12(1):53-7. PubMed ID: 14505155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiography-guided pericardiocentesis as the method of choice for treatment of significant pericardial effusion following cardiac surgery: a 12-year single-center experience.
    Kolek M; Brat R
    Minerva Cardioangiol; 2017 Aug; 65(4):336-347. PubMed ID: 28249381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapericardial treatment of neoplastic pericardial effusions.
    Martinoni A; Cipolla CM; Civelli M; Cardinale D; Lamantia G; Colleoni M; DeBraud F; Susini G; Martinelli G; Goldhirsh A; Fiorentini C
    Herz; 2000 Dec; 25(8):787-93. PubMed ID: 11200128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.
    Quattrocchi KB; Miller CH; Cush S; Bernard SA; Dull ST; Smith M; Gudeman S; Varia MA
    J Neurooncol; 1999; 45(2):141-57. PubMed ID: 10778730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapericardial cisplatin administration after pericardiocentesis in patients with lung adenocarcinoma and malignant cardiac tamponade.
    Bischiniotis TS; Lafaras CT; Platogiannis DN; Moldovan L; Barbetakis NG; Katseas GP
    Hellenic J Cardiol; 2005; 46(5):324-9. PubMed ID: 16295940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of neoplastic pericardial effusions.
    Cozzi S; Montanara S; Luraschi A; Fedeli P; Buscaglia P; Amodei V; Fossati O; Gioria A; Garzoli E; Ferrari G
    Tumori; 2010; 96(6):926-9. PubMed ID: 21388053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).
    Nguyen LT; Yen PH; Nie J; Liadis N; Ghazarian D; Al-Habeeb A; Easson A; Leong W; Lipa J; McCready D; Reedijk M; Hogg D; Joshua AM; Quirt I; Messner H; Shaw P; Crump M; Sharon E; Ohashi PS
    PLoS One; 2010 Nov; 5(11):e13940. PubMed ID: 21085676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of intrapericardial cisplatin administration in cases of recurrent malignant pericardial effusion and cardiac tamponade].
    Tomkowski W; Szturmowicz M; Borowiec B; Burakowski J; Fijałkowska A; Kober J; Filipecki S
    Pneumonol Alergol Pol; 1996; 64 Suppl 2():180-6. PubMed ID: 9181888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of children with a large pericardial effusion and cardiac tamponade.
    Guven H; Bakiler AR; Ulger Z; Iseri B; Kozan M; Dorak C
    Acta Cardiol; 2007 Apr; 62(2):129-33. PubMed ID: 17536600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contrast medium echocardiography-assisted pericardial drainage].
    Caspari G; Bartel T; Möhlenkamp S; Bersch B; von Birgelen C; Krapp J; Erbel R
    Herz; 2000 Dec; 25(8):755-60. PubMed ID: 11200124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.
    Santin AD; Bellone S; Palmieri M; Bossini B; Roman JJ; Cannon MJ; Bignotti E; Canè S; Pecorelli S
    Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and propagation of tumor-infiltrating lymphocytes from malignant pleural effusion and ascites with engineered cells for costimulatory enhancement.
    Xu Q; Shao J; Su S; Wei J; Chen F; Meng F; Zhao Y; Du J; Zou Z; Qian X; Liu B
    Cell Immunol; 2018 Sep; 331():1-8. PubMed ID: 29903664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.